Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SloMo2: A Process Evaluation, Effectiveness, and Cost-effectiveness Study of a Digitally Supported Therapy for Psychosis in Routine Care

NCT06568081 is registered in ClinicalTrials.gov with King's College London as lead sponsor.

NCT NCT06568081
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06568081 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SloMo2: A Process Evaluation, Effectiveness, and Cost-effectiveness Study of a Digitally Supported Therapy for Psychosis in Routine Care
Lead sponsor
King's College London
Phase
Not applicable
Overall status
Recruiting
Start date
October 16, 2024
Completion date
December 31, 2027
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

affective psychoses, schizophrenia spectrum and other psychotic disorders